Risk of Colonic Neoplasia After Liver Transplantation for Primary Sclerosing Cholangitis
Authors:
Open Access
- 1 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 18 (2) , 269-274
Abstract
Background. Primary sclerosing cholangitis (PSC) confers an increased risk of colon cancer in patients with inflammatory bowel disease (IBD). However, tKeywords
This publication has 32 references indexed in Scilit:
- Colorectal and anal neoplasms following liver transplantationColorectal Disease, 2010
- Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative ColitisGastroenterology, 2010
- The impact of disease recurrence on graft survival following liver transplantation: a single centre experienceTransplant International, 2008
- Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control StudyGastroenterology, 2006
- Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, MinnesotaGastroenterology, 2006
- The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitisAlimentary Pharmacology & Therapeutics, 2005
- The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitisGastroenterology, 1997
- The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugationGastroenterology, 1995
- Pretransplantation Assessment of the Risk of Lymphoproliferative DisorderClinical Infectious Diseases, 1995
- FAECAL BILE ACIDS, DYSPLASIA, AND CARCINOMA IN ULCERATIVE COLITISThe Lancet, 1987